Skip to main content

Madrigal Pharmaceuticals, Inc.

MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001157601

In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Madrigal Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
135
−2 vs. Q2 2022
Shares held
11.7M
−262.0K (−2.2%) vs. Q2 2022
Total value
$763.2M
−$94.5M (−11.0%) vs. Q2 2022
New holders
18
54 more added
Sold out
20
32 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting MDGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 135 institutions
Q1 2021: 137 institutionsQ2 2021: 151 institutionsQ3 2021: 133 institutionsQ4 2021: 144 institutionsQ1 2022: 140 institutionsQ2 2022: 138 institutionsQ3 2022: 135 institutionsQ4 2022: 189 institutionsQ1 2023: 223 institutionsQ2 2023: 208 institutionsQ3 2023: 206 institutionsQ4 2023: 226 institutionsQ1 2024: 266 institutionsQ2 2024: 257 institutionsQ3 2024: 257 institutionsQ4 2024: 283 institutionsQ1 2025: 321 institutionsQ2 2025: 305 institutionsQ3 2025: 352 institutionsQ4 2025: 387 institutionsQ1 2026: 380 institutionsQ2 2026: 414 institutions
Value heldQ3 2022: $763.2M
Q1 2021: $1.43BQ2 2021: $1.09BQ3 2021: $876.5MQ4 2021: $1.01BQ1 2022: $1.20BQ2 2022: $857.7MQ3 2022: $763.2MQ4 2022: $3.86BQ1 2023: $3.36BQ2 2023: $3.43BQ3 2023: $2.54BQ4 2023: $4.57BQ1 2024: $5.64BQ2 2024: $6.41BQ3 2024: $4.77BQ4 2024: $7.08BQ1 2025: $7.85BQ2 2025: $7.13BQ3 2025: $10.7BQ4 2025: $13.7BQ1 2026: $12.4BQ2 2026: $12.7B
Institutions holding MDGL and their total value by quarter
QuarterHoldersValue
Q2 2026414$12.7B
Q1 2026380$12.4B
Q4 2025387$13.7B
Q3 2025352$10.7B
Q2 2025305$7.13B
Q1 2025321$7.85B
Q4 2024283$7.08B
Q3 2024257$4.77B
Q2 2024257$6.41B
Q1 2024266$5.64B
Q4 2023226$4.57B
Q3 2023206$2.54B
Q2 2023208$3.43B
Q1 2023223$3.36B
Q4 2022189$3.86B
Q3 2022135$763.2M
Q2 2022138$857.7M
Q1 2022140$1.20B
Q4 2021144$1.01B
Q3 2021133$876.5M
Q2 2021151$1.09B
Q1 2021137$1.43B

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Madrigal Pharmaceuticals, Inc.; share changes are against Q2 2022.

Institutions holding MDGL in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Bank of New York Mellon Corp40,702$2.65M0.00%+4,208+11.5%Added
Citadel Advisors LLC42,144$2.74M0.00%−10,443−19.9%Reduced
Barclays PLC43,415$2.82M0.00%+35,776+468.3%Added
MPM Oncology Impact Management LP44,747$2.91M0.69%−253−0.6%Reduced
Dimensional Fund Advisors LP45,995$2.99M0.00%−123,299−72.8%Reduced
Price T Rowe Associates Inc46,621$3.03M0.00%+4,219+10.0%Added
Hennion & Walsh Asset Management, Inc.51,007$3.31M0.22%−8,336−14.0%Reduced
Deutsche Bank AG51,450$3.34M0.00%+2,078+4.2%Added
Morgan Stanley59,064$3.84M0.00%−23,889−28.8%Reduced
Citigroup Inc60,247$3.92M0.01%+27,931+86.4%Added
Rafferty Asset Management, LLC65,921$4.28M0.05%+34,761+111.6%Added
Schonfeld Strategic Advisors LLC68,736$4.46M0.04%+56,389+456.7%Added
Pictet Asset Management SA73,001$4.74M0.01%+23,403+47.2%Added
Tao Capital Management LP77,657$5.05M3.31%00.0%Unchanged
Janus Henderson Group PLC86,383$5.61M0.00%+86,383New
Charles Schwab Investment Management Inc89,479$5.82M0.00%+1,229+1.4%Added
Great Point Partners LLC95,500$6.21M1.49%+95,500New
Affinity Asset Advisors, LLC100,000$6.50M3.00%00.0%Unchanged
Northern Trust Corp113,405$7.37M0.00%−1,590−1.4%Reduced
Jennison Associates LLC113,500$7.38M0.01%−68,946−37.8%Reduced
Norges Bank116,300$7.56M0.00%+6,794+6.2%Added
L1 Capital Pty Ltd161,163$10.5M2.05%−6,840−4.1%Reduced
FMR LLC163,774$10.6M0.00%+160+0.1%Added
Goldman Sachs Group Inc180,402$11.7M0.00%+127,776+242.8%Added
Artisan Partners Limited Partnership210,482$13.7M0.02%−1,237−0.6%Reduced
Geode Capital Management, LLC229,786$14.9M0.00%+4,984+2.2%Added
Federated Hermes, Inc.240,000$15.6M0.05%00.0%Unchanged
Rock Springs Capital Management LP317,485$20.6M0.53%00.0%Unchanged
Perceptive Advisors LLC331,023$21.5M0.63%−36,478−9.9%Reduced
State Street Corp966,641$62.8M0.00%+141,334+17.1%Added
BlackRock Inc.999,504$65.0M0.00%+1,058+0.1%Added
Armistice Capital, LLC1,236,000$80.3M2.02%+136,000+12.4%Added
Vanguard Group Inc1,254,305$81.5M0.00%+22,322+1.8%Added
Baker Bros. Advisors LP1,499,213$97.4M0.64%00.0%Unchanged
Avoro Capital Advisors LLC1,535,000$99.8M1.84%00.0%Unchanged
Deep Track Capital, LP0$00.00%−905,000−100.0%Sold out
Jane Street Group, LLC0$00.00%−27,392−100.0%Sold out
Qube Research & Technologies Ltd0$00.00%−10,327−100.0%Sold out
Wolverine Trading, LLC0$00.00%−6,565−100.0%Sold out
ETF Managers Group, LLC0$00.00%−6,518−100.0%Sold out
Squarepoint Ops LLC0$00.00%−4,074−100.0%Sold out
Virtu Financial LLC0$00.00%−3,273−100.0%Sold out
DAFNA Capital Management LLC0$00.00%−3,100−100.0%Sold out
Brookfield Asset Management Inc.0$00.00%−3,075−100.0%Sold out
Forum Financial Management, LP0$00.00%−2,976−100.0%Sold out
Altshuler Shaham Ltd0$00.00%−2,135−100.0%Sold out
Silvant Capital Management LLC0$00.00%−1,213−100.0%Sold out
National Bank of Canada0$00.00%−180−100.0%Sold out
Captrust Financial Advisors0$00.00%−173−100.0%Sold out
State of Wyoming0$00.00%−128−100.0%Sold out
CoreCap Advisors, LLC0$00.00%−68−100.0%Sold out
Prospera Financial Services Inc0$00.00%−39−100.0%Sold out
Patriot Financial Group Insurance Agency, LLC0$00.00%−20−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−3−100.0%Sold out
PEAK6 Investments LLC0$00.00%−2,187−100.0%Sold out
Exane Derivatives––––Not filed